CoQ10 benefits: what the research does and doesn't show

The evidence doesn't support CoQ10 as a proven fix for any everyday goal at a single, established dose. The trials that found effects used set doses, mixed forms, and often people with a diagnosed condition, and the most-cited one found no change in its short-term endpoints. Here is what each study tested, and what it did not.

What the evidence doesn't support

It doesn't support CoQ10 as a treatment for any disease. It doesn't give a dose that works for "general wellness", energy, heart, skin, fertility or liver goals: we did not research most of those outcomes, none of the trials we read tested them, and none could be matched to a particular dose of a particular form. It doesn't show that ubiquinone and ubiquinol differ in effect, because the only two direct comparisons we found measured blood levels, not effects, and disagree: in 12 healthy adults ubiquinol at 200 mg a day raised plasma CoQ10 more than ubiquinone in a softgel, taken in sequence by authors from a CoQ10 laboratory (Langsjoen 2014), while a single 100 mg dose in 21 older adults showed no significant difference (Pravst 2020). And it doesn't show that low CoQ10 intake is something to correct: average dietary intake is only 3-6 mg a day (Pravst 2010), and the trials below gave 100 to 300 mg.

What the trials found

Fatigue ratings, pooled. A 2022 meta-analysis pooled 13 randomised trials in 1,126 healthy and diseased people. CoQ10 lowered fatigue scores versus placebo (Hedges' g -0.398, 95% CI -0.641 to -0.155), a small-to-moderate effect; the effect was significant in CoQ10-only formulations but not in "CoQ10 compound" subgroups, and larger at higher daily doses and longer durations. Doses and forms were pooled, so no single dose can be read from it, and one of the authors declared founding a company (Tsai 2022).

Exercise fatigue, one small trial. In a crossover of 17 healthy volunteers, 300 mg a day for 8 days gave a smaller fall in 10-second sprint velocity and a lower fatigue rating after a cycling task than placebo. The abstract reports no effect statement for the 100 mg arm, and it does not say whether the CoQ10 was ubiquinone or ubiquinol. It was 17 people, 8 days, one lab (Mizuno 2008). Nobody tested 200 mg.

Exercise and muscle markers, pooled. A 2024 meta-analysis of 28 randomised trials in 830 adults found CoQ10 lowered creatine kinase, lactate dehydrogenase and malondialdehyde, which are blood markers of muscle damage and oxidative stress. Performance and total antioxidant capacity did not change significantly. Most trials were in Asia, doses and forms were pooled, and the authors asked for larger, longer trials elsewhere (Talebi 2024). A blood marker moving is not the same as someone recovering faster, and this analysis did not show the latter.

Heart failure, one large trial. Q-SYMBIO randomised 420 patients with moderate to severe chronic heart failure to 300 mg a day (100 mg three times) or placebo, on top of standard treatment, for 2 years. The 16-week endpoints (NYHA class, 6-minute walk, NT-proBNP) did not change significantly. The 2-year composite of major adverse cardiovascular events occurred in 15% on CoQ10 and 26% on placebo (Mortensen 2014). These were people with a diagnosed disease, receiving treatment, and the abstract does not state the form. This is not evidence for people without heart failure, and CoQ10 is not a treatment for it.

Muscle symptoms in statin users, pooled. A 2022 meta-analysis of 8 randomised trials in 472 people taking statins with muscle symptoms found CoQ10 did not significantly change creatine kinase (mean difference 3.29 U/L, 95% CI -29.58 to 36.17) or muscle pain (standardised mean difference -0.59, 95% CI -1.54 to 0.36) compared with placebo. The authors concluded there was no significant benefit. The abstract gives no dose or form (Wei 2022). That is the studied population, not advice about any medicine: decisions about a prescription belong to the prescriber.

Across these, the doses that showed an effect were 300 mg a day or pooled across many doses. We found no trial of 200 mg of ubiquinone for any outcome.

Questions people ask

What are the benefits of CoQ10, and what is CoQ10 good for?

The studied outcomes are above: fatigue ratings, exercise-related blood markers, and long-term events in heart failure. Each has the limits stated with it. None of it establishes a benefit at one dose for people in general.

Is CoQ10 good for you, and what does it do for the body?

In cells it is a component of the mitochondrial electron transport chain (Tsai 2022). Whether supplementing changes how you feel is what the trials above tried to measure, with mixed and limited results. The safety literature found no dose-related side effects from 60 to 1,200 mg a day, though it was written by an industry trade body (Hathcock 2006).

Is CoQ10 good for the heart?

The one large trial is the heart failure study above: 420 patients, 300 mg a day, short-term endpoints unchanged, later events lower. We found no trial of a supplement in people without heart disease that we could cite for a heart outcome. See your cardiologist or doctor about heart conditions.

Is CoQ10 good for fertility, egg quality, skin, hair, liver, kidneys or joint pain?

We did not research these topics and make no statement about them. We reviewed none of the trials in those areas, and the trials we did read did not measure them.

What does CoQ10 do with statins, and is it good when taking them?

The pooled trials in statin users found no significant change in muscle pain or creatine kinase (above). Whether to take any supplement alongside a prescription is a question for the prescriber.

Are there benefits for women or for men?

None of the trials above reported a result specific to either sex. A sex difference was noted in a 1994 absorption study of 10 healthy people, which is about blood levels, not benefit.

Do the benefits differ at 100, 200, 300, 400 or 600 mg?

The only trial we read that compared two doses (100 and 300 mg) reported an effect for 300 mg only. The 2022 pooled analysis found larger fatigue effects at higher daily doses. No trial we read tested 200, 400 or 600 mg of ubiquinone against placebo, so we can't say what any of them would do.

How long does CoQ10 take to work?

The studies measured outcomes over 8 days (the cycling trial), longer in the pooled analyses, and 2 years in the heart failure trial. A 2022 analysis linked longer treatment duration to larger fatigue effects. We can't give a time to expect an effect for a person.

When to talk to a doctor

CoQ10 is not a treatment for heart failure, muscle symptoms, fatigue that won't lift, or any other condition. Persistent fatigue, muscle pain, or heart symptoms need a clinician to find the cause. If you take prescription medicine, check with your prescriber or pharmacist before adding any supplement. For what CoQ10 is and how it is made, see what is CoQ10; for doses and safety, see CoQ10 dosage and CoQ10 side effects.